New EU research project started

+++ European Research "ARTreat" +++ Fighting artheriosclerosis +++ Main cause of death in Europe+++

Artheriosclerosis - this creeping disease which often remains undetected over years is in the main focus of many medical and biochemical research activities.
Characterised by a progressive degeneration of the arterial wall with the build-up of plaques to these walls, artheriosclerosis manifests itself with ischaemia, thrombosis, heard attack, stroke and sudden death.

ASD participates in a new European Research Project with 18 partners from 13 countries and a financial volume of 10,5 Mio Euro. "ARTreat" started in September 2008 and creates patient-specific models of the cardiovascular system and of artheriosclerotic plaque formation. The ambitious aim of the project is to provide cardiologists and vascular surgeons with tools which will be able to support them before, during and after a clinical intervention.

A three-level patient model will allow
·    the reconstruction of the three-dimensional patient geometry,
·    the modelling of the patient-specific blood flow, blood particle dynamics and biological processes leading
     to plaque formation,
·    the simulation of the interventionial procedures to treat plaqued arteries

Within "ARTreat", ASD will apply its long-term experiences in the area of virtual stenting procedures as well as the company's expertise in the simulation of complex physical-biological processes to investigate blood flow and coagulation behaviour in blood vessels.